Moderna (MRNA) PT Raised to $150 at BofA Securities on Updated SOTP
Tweet Send to a Friend
BofA Securities analyst Geoff Meacham raised the price target on Moderna (NASDAQ: MRNA) to $150.00 (from $105.00) after performing a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
